Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer (Thunder Endom)
|ClinicalTrials.gov Identifier: NCT01717794|
Recruitment Status : Unknown
Verified November 2012 by Prof. Giovanni Scambia, Catholic University of the Sacred Heart.
Recruitment status was: Recruiting
First Posted : October 30, 2012
Last Update Posted : November 6, 2012
This prospective randomized pilot study is aimed to verify if the operative time of a TLH with pelvic lymphadenectomy for endometrial cancer FIGO stage IB-II could be reduced using Thunderbeat (an ultrasonic energy device that incises and coagulates by using ultrasonic and bipolar technology ) (Olympus Medical Systems Corp, Tokyo) vs. bipolar electrosurgery .
Secondary endpoints of this comparison are incidence of intra- or postoperative complications (Cardiac, Respiratory, Neurological, Gastrointestinal, Renal, Fever, Wound or other Infection, Lymphocele), estimated blood loss, postoperative pain (evaluated by VAS), days of hospitalization and costs for the health care system.
|Condition or disease||Intervention/treatment|
|Endometrial Cancer||Procedure: Thunderbeat technology Procedure: Standard bipolar electrosurgery|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||36 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prospective Randomized Trial on Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Endometrial Cancer FIGO Stage IB-II: Thunderbeat Technology Versus Standard Bipolar Electro-surgery.|
|Study Start Date :||October 2012|
|Estimated Primary Completion Date :||October 2014|
Active Comparator: Standard bipolar electrosurgery
Laparoscopic total hysterectomy with pelvic lymphadenectomy are performed with standard bipolar electrosurgery.
A 10 mm port is inserted at the umbilicus for the telescope. Once pneumoperitoneum (12 mmHg) is achieved, intra-abdominal visualization will be obtained with a 0° high-definition telescope.
Two additional 5 mm ports are placed under direct visualization. One more 5-mm trocar is inserted in the right mid abdomen at the level of the umbilicus. The instruments used include bipolar grasper, monopolar scissors, monopolar hook, various graspers and a suction irrigation system.
|Procedure: Standard bipolar electrosurgery|
Experimental: Thunderbeat technology
Laparoscopic total hysterectomy with pelvic lymphadenectomy are performed with Thunderbeat technology: using Thunderbeat technique, surgeons can avoid changing instruments during surgery since Thunderbeat combines bipolar energy for haemostasis and ultrasound for dissection and cut.
Thunderbeat is used to coagulate the fallopian tubes, to coagulate and divide the round ligaments, to seal ovarian pedicles, to open the anterior and posteriors leaves of the broad ligaments peritoneum, to develop the paravesical and pararectal spaces, to seal uterine arteries and uterine pedicles, to incise the bladder peritoneum, to dissect the bladder, to develop rectovaginal septum, to cut parametria, and to divide the uterosacral ligaments. Thunderbeat is also used to perform the pelvic lymphadenectomy and, if necessary, the para-aortic lymphadenectomy.
|Procedure: Thunderbeat technology|
- Operative time for total laparoscopic hysterectomy with pelvic lymphadenectomy [ Time Frame: 24 months ]Operative time will be calculated from the entrance in the abdominal cavity to the closure of the skin trocar accesses.
- Intra- or post operative complications [ Time Frame: 24 months ]Cardiac, Respiratory, Neurological, Gastrointestinal, Renal, Fever, Wound or other Infection, Lymphocele
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01717794
|Contact: Catholic University of Sacred the Hearth||+39 063 015 627 9|
|Catholic University of Sacred the Hearth||Recruiting|
|Rome, Italy, 00100|
|Principal Investigator: Anna Fagotti, PhD|
|Principal Investigator: Francesco Fanfani, MD|
|Principal Investigator: Valerio Gallotta, MD|
|Principal Investigator: Giuseppe Vizzielli, MD|
|Principal Investigator: Elisa Piovano, MD|
|Principal Investigator: Raffaella Iodice|